Get notified when SER files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (new) — The auditor's report includes a going concern warning, indicating substantial doubt about the company's ability to continue operating.
NYSE: SER Serina Therapeutics, Inc. 424B5

Serina Therapeutics launches $13.3M at-the-market offering at $6.09/share; implied market cap $60.7M

Filed April 28, 2025 · ~1 min read

Key Changes

  • high

    Serina Therapeutics may sell up to $13,270,500 of common stock in an at-the-market offering through JonesTrading, with proceeds to the company.

    The Offering verify on EDGAR →
  • high

    The offering price is not fixed; shares will be sold at market prices, with $6.09 per share used as an example based on the last reported sale price on April 24, 2025.

    The Offering verify on EDGAR →
  • high

    New investors face immediate dilution of $5.001 per share, as the as-adjusted net tangible book value per share is only $1.089 after the offering.

    Dilution verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (GIS 10-Q) is open in full — no account needed.

Partner

Trade SER commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify